Cargando...
Nucleotide analogues as inhibitors of SARS‐CoV Polymerase
SARS‐CoV‐2, a member of the coronavirus family, has caused a global public health emergency. Based on our analysis of hepatitis C virus and coronavirus replication, and the molecular structures and activities of viral inhibitors, we previously reasoned that the FDA‐approved hepatitis C drug EPCLUSA...
Gardado en:
| Publicado en: | Pharmacol Res Perspect |
|---|---|
| Main Authors: | , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
John Wiley and Sons Inc.
2020
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7596664/ https://ncbi.nlm.nih.gov/pubmed/33124786 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/prp2.674 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|